Worries over budget fights in Washington sent stocks lower this past Friday but Shutterstock shares soared and even hit a new 52-week high of $70.80. The Company priced an offering of 4.6 million shares at $60.00 last week. 3.6 mln shares of the common stock in this offering belong to existing shareholders including the CEO Jon Oringer.
Growlife, Inc. (OTCBB: PHOT) – shares closed down 6.95% last Friday with a little over 11.6 million shares traded. Earlier this month the Company announced that it will open its 7th hydroponic retail location in Santa Rosa, CA in October. Growlife has core holdings in innovative technology-based products and services for the indoor gardening industry and specialty markets.
OncoSec Medical Incorporated (OTC: ONCS) – shares modestly closed in the green up 0.19% after announcing early Friday morning that the Company will present at the 2013 Aegis Capital Healthcare Conference on September 26th in Las Vegas, Nevada. OncoSec Medical is developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors.
Shutterstock, Inc. (NYSE: SSTK) –Shares hit a new 52-week high of 70.80 last Friday after the company announced the pricing of its follow-on offering of 4.6 million shares of its common stock at a price to the public of $60.00 per share. Shutterstock closed up 16.73% with roughly 3.3 million shares traded. The stock is up more than 200% since the company’s IPO price of $21.00.
Elite Pharmaceuticals, Inc. (OTCBB: ELTP) – Trading volume last Friday was almost four times higher than average for the stock with over 8.2 million shares traded. Shares of Elite closed modestly in the green up 2.90%. The company announced last week its first shipment of generic Naltrexone Hydrochloride.
To find similar research reports that are available for free follow the link below and sign up at http://www.stockfreak.com/
StockFreak.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
For Media Only
Leave a comment...